HER2 Low Breast Cancer: New Clinical Entity or Testing Artifact? ...Middle East

Medscape - News
One of the problems with the new subgroup of HER2 low tumors is that using current assays to measure low levels "is like weighing mice on a scale built for elephants," says one expert. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( HER2 Low Breast Cancer: New Clinical Entity or Testing Artifact? )

Apple Storegoogle play

Also on site :



Latest News